Rammah Abohtyra;Yossi Chait;Joseph Horowitz;Christopher V. Hollot;Michael J. Germain
发明人:
Rammah Abohtyra,Yossi Chait,Christopher V. Hollot,Joseph Horowitz,Michael J. Germain
申请号：
US16545184
公开号：
US20200054814A1
申请日:
2019.08.20
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Hemodialysis is used to remove fluid from a patient suffering from end-stage renal kidney disease. An optimization-based approach including a design of an individualized ultrafiltration rate profile may be used to prevent hematocrit levels from exceeding a threshold, thereby preventing adverse effects in the patient. The individualized ultrafiltration rate profile may be based on previously obtained clinical data for the patient, a volume of fluid to be removed from the patient, a specified period of time for removal of the fluid, or a patient-specific fluid volume model. The ultrafiltration rate profile may be time-variant over the specified period of time.
